1-159306130-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001387280.1(FCER1A):c.474C>A(p.Asn158Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001387280.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCER1A | NM_001387280.1 | c.474C>A | p.Asn158Lys | missense_variant | Exon 4 of 5 | ENST00000693622.1 | NP_001374209.1 | |
FCER1A | NM_002001.4 | c.474C>A | p.Asn158Lys | missense_variant | Exon 6 of 7 | NP_001992.1 | ||
FCER1A | NM_001387282.1 | c.375C>A | p.Asn125Lys | missense_variant | Exon 4 of 5 | NP_001374211.1 | ||
FCER1A | NM_001387281.1 | c.219C>A | p.Asn73Lys | missense_variant | Exon 3 of 4 | NP_001374210.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FCER1A | ENST00000693622.1 | c.474C>A | p.Asn158Lys | missense_variant | Exon 4 of 5 | NM_001387280.1 | ENSP00000509626.1 | |||
FCER1A | ENST00000368115.5 | c.474C>A | p.Asn158Lys | missense_variant | Exon 5 of 6 | 1 | ENSP00000357097.1 | |||
FCER1A | ENST00000368114.1 | c.375C>A | p.Asn125Lys | missense_variant | Exon 4 of 5 | 3 | ENSP00000357096.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.474C>A (p.N158K) alteration is located in exon 6 (coding exon 4) of the FCER1A gene. This alteration results from a C to A substitution at nucleotide position 474, causing the asparagine (N) at amino acid position 158 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.